Therefore, researchers are increasingly adopting more clinically relevant transgenic amyloid-beta animal models (e.g., APP/PS1, 3xTg-AD) to simulate AD’s intricate mechanisms, though these studies are scarce and have their serious limitations too [7,22]. Here, APP is linked to Alzheimer disease.